New Data from the Phase 3b ESCAPE-TRD Study Show that Participants Receiving SPRAVATO®▼(Esketamine Nasal Spray [NS]) Achieved Higher Response and Remission Rates, Increasing Over Time, Compared to those Receiving Quetiapine Extended-Release
Findings presented at the 31st European Congress of Psychiatry (EPA 2023) confirm the importance of…
Lance A. Slatton Named Brand Ambassador for BareFoot Sandal, Championing Mobility, Confidence, and Independence
CEO.CA’s Inside the Boardroom: Goldinxs Targeting Major Discovery Near Artemis Gold’s Blackwater Mine
CEO.CA’s Inside the Boardroom: No Approved Drug Does What Marvel’s Lead Candidate Can Do for Autism
DFW Lonestar Rentals Surpasses 600 Vehicles And Expands Fleet Inventory
Uniserve Provides Vancouver Data Centre Update and Advances Canadian Digital Infrastructure Strategy